This is a study involving a dietary supplement. Patients with argininosuccinate lyase deficiency (ASLD) will be randomly assigned to receive either a nitric oxide dietary supplement or placebo for 24 weeks, and then crossed-over to receive the other treatment for 24 weeks. The investigators will assess the effects of the supplement in domains of general cognition, memory, executive functioning, and fine motor functioning in individuals with ASLD.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Delis-Kaplan Executive Function System - Tower subtest
Timeframe: 24 weeks
Stanford-Binet - 4th Edition: Bead Memory and Sentence Memory subtests
Timeframe: 24 weeks
Grip Strength
Timeframe: 24 weeks
Grooved Pegboard
Timeframe: 24 weeks
Wechsler Intelligence Scale for Children OR Wechsler Adult Intelligence Scale - 4th Edition (in subjects > 16 years of age)
Timeframe: 24 weeks
Tower of London Test
Timeframe: 24 weeks
Conners Continuous Performance Test - 3rd Edition Conners Continuous Performance Test - 3rd Edition
Timeframe: 24 weeks